SAN || Atopic Dermatitis | European Federation of Internal Medicine

WCD: Methotrexate found safer but less effective than cyclosporine in atopic dermatitis

Posted on: 27/06/2015 - 19:20

VANCOUVER, B.C. – In the first head-to-head trial in atopic dermatitis, cyclosporine was about five times more effective in terms of SCORAD 50 but was associated with more adverse events, Dr....

Field of Interest: Dermatology

Type: News Item

WCD: Smoking tied to worse occupational hand eczema

Posted on: 27/06/2015 - 18:57

VANCOUVER, B.C. – Occupational hand eczema is worse and more persistent in smokers than nonsmokers, a large prospective cohort study found. “Tobacco smoking is associated with work absenteeism and...

Field of Interest: Dermatology

Type: News Item

WCD: Restoring microbiome might ease atopic dermatitis

Posted on: 22/06/2015 - 21:31

VANCOUVER, B.C. – Manipulating the skin microbiome might one day help control atopic dermatitis, Dr. Thomas Bieber said at the World Congress of Dermatology. Scientists used to focus mainly on...

Field of Interest: Dermatology

Type: News Item

Majority of eczema appears after childhood

Posted on: 09/06/2015 - 18:56

Though atopic dermatitis is often regarded as infrequent in adulthood, only 40% of study subjects with current eczema reported onset of the disease in childhood, with most beginning after adulthood,...

Field of Interest: Dermatology

Type: News Item

Consider combining therapies for atopic dermatitis

Posted on: 09/06/2015 - 18:45

Cyclosporine and oral antihistamine therapy showed inconsistent effects on clinical and laboratory markers of atopic dermatitis in older children and adults, based on data from a study of 48...

Field of Interest: Dermatology

Type: News Item

VIDEO: Get excited about the excimer laser for dermatitis

Posted on: 13/05/2015 - 18:36

ASHEVILLE, N.C. – Excimer lasers can be used for patients with allergic contact dermatitis for whom topical therapies are unsuccessful or undesirabl... More »

Field of Interest: Dermatology

Type: News Item

Dupilumab improves moderate to severe atopic dermatitis in adults

Posted on: 22/03/2015 - 19:24

SAN FRANCISCO– Dupilumab met its safety endpoints and significantly outperformed placebo for adults with moderate to severe atopic dermatitis, accor... More »

Field of Interest: Dermatology

Type: News Item

Contact allergen of 2015: Formaldehyde

Posted on: 21/03/2015 - 18:27

SAN FRANCISCO – Formaldehyde has been named the American Contact Dermatitis Society Contact Allergen of the Year for 2015, Dr. David E. Cohen said i... More »

Field of Interest: Dermatology

Type: News Item

Maintenance tacrolimus for eczema boosts quality of life

Posted on: 15/12/2014 - 14:13

AMSTERDAM – Twice-weekly proactive maintenance therapy with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis resulted in dramatic improvement in self-reported quality of...

Field of Interest: Dermatology

Type: News Item

Dupilumab advances for severe atopic dermatitis

Posted on: 18/11/2014 - 19:45

AMSTERDAM – The novel biologic agent dupilumab showed strong dose-dependent efficacy in adults with moderate to severe atopic dermatitis not adequately controlled with topical medications in a...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

Latest Newsletters